Skip to main content

MORGAN STANLEY

Position in RGC — Regencell Bioscience Holdings Ltd

CIK 895421 NEW YORK, NY

Position in RGC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$30,764
-$479,818 QoQ
Shares Held
5,052
-74.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 35 holders
Holding Since
Sep 2021
15 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in RGC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $3,507,440,445 across 76 Drug Manufacturers - Specialty & Generic names. RGC ranks #57 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RGC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $30,764 5,052
2026-03-31 $510,582 20,078
2025-12-31 $449,904 21,424
2025-09-30 $584,658 37,842
2025-06-30 $562,659 33,020
2025-03-31 $159 5
2024-12-31 $10,374 2,100
2023-09-30 $4,645 326
2023-06-30 $6,934 301
2023-03-31 $7,686 297
2022-12-31 $7,836 281
2022-09-30 $7,217 227
2022-06-30 $5,155 149
2022-03-31 $128 6
2021-09-30 $11,393 503